Phase I trial of daily subcutaneous SPL-108 injections in combination with paclitaxel in patients with platinum resistant CD44+ advanced ovarian epithelial cancer.
Int J Gynecol Cancer
; 2022 Jun 24.
Article
in En
| MEDLINE
| ID: mdl-35750354
Full text:
1
Database:
MEDLINE
Language:
En
Journal:
Int J Gynecol Cancer
Journal subject:
GINECOLOGIA
/
NEOPLASIAS
Year:
2022
Type:
Article
Affiliation country:
United States